Abstract
To assess the clinical management and mortality associated with cryptococcal meningitis (CM) in acquired immunodeficiency syndrome (AIDS) patients in Kenya. Cryptococcal meningitis (CM) is an increasingly prevalent infection among AIDS patients and is becoming a leading cause of morbidity and mortality in Africa. The short-term prognosis and management of patients with CM may be improved by identifying factors leading to mortality in CM patients. A retrospective chart review of 76 HIV-infected CM patients admitted between August 2008 and March 2009 at Kenyatta National Hospital and Mbagathi District Hospital. Seventy six confirmed CM positive patients. Results show that 30 (40%) of 76 patients diagnosed with CM died during hospitalization after a median hospital stay of 10 days (range, 2–73 days). Significant predictors of mortality in the univariate model were Mycobacterium tuberculosis (TB) co-infection (P = 0.04), having been diagnosed with a co-morbid condition such as diabetes, oral candidiasis and hypertension (P = 0.01), and a low median CD4+ T lymphocyte count (P < 0.001). The multivariable model revealed that male sex, previous or current ART at admission and CD4+ T lymphocyte count less than 50 were significant predictors of mortality. Conversely, a minimum of two weeks of amphotericin B treatment (P < 0.001), initiation of antiretroviral therapy (ART) (P = 0.007) and monitoring of creatinine and electrolyte levels (P = 0.02) were significantly associated with survival in the univariate model. These results demonstrate the CM-associated mortality in Kenya is high and that there is an opportunity to improve the management and the short-term outcomes of hospitalized HIV positive patients with CM.